Is Therapeutic Plasma Exchange Indicated for Patients with Gemcitabine-Induced Hemolytic Uremic Syndrome?

被引:42
作者
Gore, Ethan McCaleb [2 ]
Jones, Benjamin Scott [2 ]
Marques, Marisa B. [1 ]
机构
[1] Univ Alabama, Div Lab Med, Dept Pathol, Birmingham, AL 35249 USA
[2] Univ S Alabama, Coll Med, Mobile, AL USA
关键词
atypical hemolytic uremic syndrome; gemeitabine; thrombotic microangiopathy; ADAMTS-13; therapeutic plasma exchange; THROMBOTIC THROMBOCYTOPENIC PURPURA; PEGYLATED LIPOSOMAL DOXORUBICIN; PHASE-II; CANCER; MICROANGIOPATHY; CHEMOTHERAPY; COMBINATION; CARCINOMA; DIAGNOSIS;
D O I
10.1002/jca.20213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atypical hemolytic uremic syndrome (aHUS) has been described as an uncommon complication of gemcitabine. In this review, we discuss the diagnosis of gemcitabine-induced aHUS (GiHUS), and the published experience with therapeutic plasma exchange (TPE). To illustrate GiHUS, we present a patient who developed hypertension and peripheral edema while receiving gemcitabine and subsequently was found to have thrombocytopenia, hemolytic anemia, renal failure, and normal ADAMTS-13 activity. Although laboratory parameters improved oil suspending gemcitabine, they worsened after reinstitution of the drug. Thrombocytopenia and hemolysis ceased once the drug was permanently discontinued without therapeutic plasma exchange (TPE). The pathological characteristics of GiHUS suggest damage of the glomeruli endothelial lining, leading to Occlusion by fibrin-rich thrombi. Among 26 patients described in the literature not treated with TPE, 56% recovered from GiHUS, whereas only 30% of 18 patients treated with TPE did. The difference in recovery rate may have been confounded by the severity of GiHUS as suggested by the rate of dialysis in each group: 10/26 (38%) patients who did not receive TPE were dialyzed compared with 11/18 (61%) of those who had plasma exchange. Thus, although the currently available evidence is not decisive for use or non use of TPE. we suggest thin the most important therapeutic intervention in GiHUS is discontinuation of the drug. Apheresis medicine specialists should be aware of this specific type of aHUS and provide treatment advice based on the Currently available evidence. J. Clin. Apheresis 24:209-214, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 50 条
[41]   Atypical Hemolytic Uremic Syndrome: Cancer-Induced or Chemotherapy-Induced? [J].
Sethi, Ashish ;
Moses, Raj .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
[42]   Hemolytic and uremic syndrome as a complication of long-term therapy with gemcitabine. [J].
Dilhuydy, MS ;
Delclaux, C ;
Pariente, A ;
De Precigout, V ;
Aparicio, M .
REVUE DE MEDECINE INTERNE, 2002, 23 (02) :189-192
[43]   Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab [J].
Vakiti, Anusha ;
Singh, Daulath ;
Pilla, Ravi ;
Alhaj-Moustafa, Muhamad ;
Fitzpatrick, Kelly W. .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (04) :1011-1015
[44]   Clinical evaluation of thrombotic microangiopathy: Identification of patients with suspected atypical hemolytic uremic syndrome [J].
Shen Y.-M. .
Thrombosis Journal, 14 (Suppl 1)
[45]   Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection —is plasma exchange or eculizumab use necessary? [J].
Ken Saida ;
Masao Ogura ;
Yuji Kano ;
Shingo Ishimori ;
Takahisa Yoshikawa ;
Hiroko Nagata ;
Mai Sato ;
Koichi Kamei ;
Kenji Ishikura .
BMC Nephrology, 19
[46]   Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection is plasma exchange or eculizumab use necessary? [J].
Saida, Ken ;
Ogura, Masao ;
Kano, Yuji ;
Ishimori, Shingo ;
Yoshikawa, Takahisa ;
Nagata, Hiroko ;
Sato, Mai ;
Kamei, Koichi ;
Ishikura, Kenji .
BMC NEPHROLOGY, 2018, 19
[47]   Plasma exchange combined with eculizumab in the management of atypical hemolytic uremic in pediatric patients: A case report [J].
Yang, Lian ;
Liu, Fan ;
Li, Xiaolu ;
He, Lanfen ;
Gu, Yan ;
Sun, Mingcan ;
Liu, Zhenzhen ;
Liu, Zeng .
MEDICINE, 2025, 104 (15)
[48]   Therapeutic plasma exchange in postpartum HELLP syndrome: a case report [J].
Kojima, Nana ;
Kuroda, Kosuke ;
Tani, Makiko ;
Kanazawa, Tomoyuki ;
Shimizu, Kazuyoshi ;
Maki, Jota ;
Masuyama, Hisashi ;
Morimatsu, Hiroshi .
JA CLINICAL REPORTS, 2023, 9 (01)
[49]   Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome [J].
Azoulay, Elie ;
Knoebl, Paul ;
Garnacho-Montero, Jose ;
Rusinova, Katerina ;
Galstian, Gennadii ;
Eggimann, Philippe ;
Abroug, Fekri ;
Benoit, Dominique ;
von Bergwelt-Baildon, Michael ;
Wendon, Julia ;
Scully, Marie .
CHEST, 2017, 152 (02) :424-434
[50]   Diagnostic and Therapeutic Challenges in Atypical Hemolytic Uremic Syndrome: A Case Report [J].
Reis, Sofia ;
Ramos, Daniela ;
Cordinha, Carolina ;
Gomes, Clara .
ACTA MEDICA PORTUGUESA, 2019, 32 (10) :673-675